Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
ViroPharma Incorporated - Company Profile

ViroPharma Incorporated - Company Profile - new company profile report published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-09-19 16:26:27 - ViroPharma Incorporated - Company Profile - a new company profile report on companiesandmarkets.com

ViroPharma Incorporated - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company´s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features

- Detailed information on ViroPharma Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting ViroPharma Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of ViroPharma Incorporated including a breakdown and examination of key business segments
- Intelligence on ViroPharma Incorporated´s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about ViroPharma Incorporated, such

 

 

as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights

ViroPharma is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases. The company is headquartered in Exton, Pennsylvania and employed 232 people as of December 31, 2010. The company recorded revenues of $439 million during the financial year ended December 2010 (FY2010), an increase of 41.4% over FY2009. The operating profit of the company was $211.7 million during FY2010, as compared to operating profit of $32.1 million in FY2009. The net profit was $125.6 million in FY2010, as compared to net loss of $11.1 million in FY2009.

Reasons to Purchase

- Gain understanding of ViroPharma Incorporated and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess ViroPharma Incorporated as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers´ businesses better
- Stay up to date on ViroPharma Incorporated´s business structure, strategy and prospects

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser